1.
Two-Year Performance and Safety Results of the MINIject Supraciliary Implant in Patients With Primary Open-Angle Glaucoma: Meta-Analysis of the STAR-I, II, III Trials.
Dick H Burkhard, Mackert Marc J, Ahmed Iqbal Ike K, Denis Philippe, Hirneiß Christoph, Flowers Brian E et al.
Am J OphthalmolDec 202314 citationsMeta-Analysis
This meta-analysis found the MINIject supraciliary implant safely and effectively lowered IOP and medication burden in POAG patients for two years, offering a bleb-free treatment option.